Global Harmonization for Data Access & Exchange

Hybrid Public Meeting
November 5, 2026 | 1-4pm (eastern)

To meet patient needs, global medical product development must move toward efficient, coordinated international regulatory submission and review of medical products - bringing high-quality drugs to market faster without compromising safety or effectiveness.

This public meeting will explore what it takes to modernize global data access and exchange. Building on the ‘Modernizing Global Data Access and Exchange’ digital report, this meeting will bring together regulators, industry, technologists, clinicians, and policy experts to discuss the current landscape and potential solutions for global data harmonization.

The deadline to request to present public comment has passed. 

We invited the public to share their interest in speaking either in-person or virtually on the following topics:

  1. What is the value of global data harmonization?
  2. What are the primary barriers and potential solutions?
 
This is a hybrid event with options to attend virtually or in person at 1333 New Hampshire Ave., NW, Washington, DC. Please note that in-person seating is limited.
 
For assistance, please contact admin@reaganudall.org.
Register to Attend In-Person
Register to Attend Virtually

Agenda

 

1Day Sooner, Amgen, Bayer, Lilly, and PhRMA provided funding for this meeting.